Mukul Agrawal is a famend Indian investor recognized for his sharp stock-picking abilities and value-driven funding strategy. With a diversified portfolio throughout sectors like finance, healthcare, and manufacturing, he has earned a powerful repute within the Indian inventory market. His strategic investments and well timed entries have constantly delivered spectacular returns, making him a revered title amongst market contributors. As per the newest company shareholdings filed, Mukul Agrawal publicly holds 71 shares with a internet value of over Rs. 7,569.2 Cr.
Listed below are the shares that gave a multibagger return in Mukul Agrawal’s portfolio within the final 1 yr;
Osel Units Ltd is a quickly increasing medical know-how firm specializing in superior diagnostic, radiology, and critical-care gear. With a powerful concentrate on innovation and affordability, it develops healthcare options geared toward bettering scientific outcomes and enhancing accessibility throughout hospitals, clinics, and diagnostic facilities. With a market capitalisation of Rs 1,349 crore, the shares closed at Rs 775 per share, decreased round 4 p.c as in comparison with the earlier closing value.
Osel Units has delivered distinctive returns, with a staggering 267% acquire over the previous yr and 160% in simply six months, reflecting sturdy market momentum. Since itemizing, the inventory surged an astounding 305%, underscoring its sturdy long-term efficiency and investor confidence in India’s capital markets and financial development trajectory.
As of September 2025, ace investor Mukul Agrawal holds 1,338,400 shares, representing a 7.6% stake, reflecting sturdy confidence within the firm’s potential. In H1FY26, the corporate posted spectacular financials with income at Rs 147 crore and a strong internet revenue of Rs 15 crore, showcasing sturdy development momentum and strong enterprise fundamentals.
Zota Healthcare Ltd is a pharmaceutical firm recognized for its branded generics, OTC merchandise, and nutraceuticals. By means of its Davaindia retail pharmacy chain, the agency focuses on inexpensive medicines, large product accessibility, and constant portfolio growth inside India’s rising healthcare market. With a market capitalisation of Rs 5,111 crore, the shares closed at Rs 1,649 per share, elevated round 0.92 p.c as in comparison with the earlier closing value.
Zota Healthcare has delivered distinctive returns, with a staggering 201% acquire over the previous yr and 68% in simply six months, reflecting sturdy market momentum. Over a five-year interval, returns surged by 1,080%, underscoring its sturdy long-term efficiency and investor confidence in India’s capital markets and financial development trajectory.
As of September 2025, ace investor Mukul Agrawal holds 2,516,989 shares, representing an 8.2 p.c stake, reflecting sturdy confidence within the firm’s potential.
ASM Applied sciences Ltd is a world engineering and product-development companies firm specialising in digital engineering, cloud, IoT, and semiconductor design. It companions with main enterprises to ship revolutionary options throughout automation, product lifecycle companies, and know-how modernisation, supporting purchasers’ international transformation wants. With a market capitalisation of Rs 5,335 crore, the shares closed at Rs 3,658 per share, decreased round 3.01 p.c as in comparison with the earlier closing value.
ASM Applied sciences has delivered distinctive returns, with a staggering 155% acquire over the previous yr and 78.29% in simply six months, reflecting sturdy market momentum. Over 5 years, returns surged an astounding 5,066.41%, underscoring its sturdy long-term efficiency and investor confidence in India’s capital markets and financial development trajectory.
As of September 2025, ace investor Mukul Agrawal holds 1,500,000 shares, representing a ten.7% stake, reflecting sturdy confidence within the firm’s potential. In Q2FY26, the corporate posted spectacular financials with income at Rs 154 crore and a strong internet revenue of Rs 19 crore, showcasing sturdy development momentum and strong enterprise fundamentals.
Written by Abhishek Singh
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/score businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Traders should subsequently train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the writer usually are not answerable for any losses brought on because of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
